HealthEquity, Inc. (HQY) Stock Analysis
Range Bound setup · Temp Headwind edge
Healthcare · Health Information Services
Hold if already holding. Not a fresh buy at $86.38, but acceptable to hold if already in. Reasons: Negative momentum; Below 200-MA, MA slope -1.1%/30d (confirmed downtrend).
HealthEquity is the largest HSA provider by number of accounts, administering 10.6 million HSAs with $36.5 billion in assets and 7.2 million complementary CDBs (FSAs, HRAs, COBRA) as of January 31, 2026. Revenue comes from service fees, custodial fees from insurance company and... Read more
Hold if already holding. Not a fresh buy at $86.38, but acceptable to hold if already in. Reasons: Negative momentum; Below 200-MA, MA slope -1.1%/30d (confirmed downtrend). Chart setup: RSI 48 mid-range, Bollinger mid-band. Maintain position. Not compelling to add more. Score 5.8/10, moderate confidence.
Passes 7/9 gates (favorable risk/reward ratio, clean insider activity, no SEC red flags, news events none recent, earnings proximity 78d clear, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum and death cross (50MA < 200MA). Suitability: moderate.
Recent developments
updated 2026-06-15Recent Developments — HealthEquity, Inc.
Latest news
- NEWS HealthEquity (HQY) Gains 1.15% as Shares Test Mid-Range Resistance - PCR Extreme - The Legal Advocate — The Legal Advocate positive
- NEWS Rep. Gilbert Ray Cisneros, Jr. Buys HealthEquity, Inc. (NASDAQ:HQY) Shares - MarketBeat — MarketBeat neutral
- NEWS The Bull Case For HealthEquity (HQY) Could Change Following Raised Earnings Outlook And Completed Buyback Program - Yaho — Yahoo Finance positive
- NEWS Why HealthEquity (HQY) is a Top Growth Stock for the Long-Term - Yahoo Finance — Yahoo Finance positive
- NEWS Why HealthEquity (HQY) is a Top Growth Stock for the Long-Term - finance.yahoo.com — finance.yahoo.com positive
Generated 2026-06-15T18:11:46Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
2 floor-breakers
Price action weak — below key moving averages, no momentum carry. Needs a base before trend-continuation setups apply.static
Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Hold if already holding. Not a fresh buy at $86.38, but acceptable to hold if already in. Reasons: Negative momentum; Below 200-MA, MA slope -1.1%/30d (confirmed downtrend). Chart setup: RSI 48 mid-range, Bollinger mid-band. Maintain position. Not compelling to add more. Target $104.01 (+20.4%), stop $80.30 (−7.6%), A.R:R 2.3:1. Score 5.8/10, moderate confidence.
Take-profit target: $104.01 (+20.5% upside). Target $104.01 (+20.4%), stop $80.30 (−7.6%), A.R:R 2.3:1. Stop-loss: $80.30.
Negative momentum; Below 200-MA, MA slope -1.1%/30d (confirmed downtrend).
HealthEquity, Inc. trades at a P/E of 33.1 (forward 16.1). TrendMatrix value score: 5.9/10. Verdict: Hold.
20 analysts cover HQY with a consensus score of 4.2/5. Average price target: $116.
What does HealthEquity, Inc. do?HealthEquity is the largest HSA provider by number of accounts, administering 10.6 million HSAs with $36.5 billion in...
HealthEquity is the largest HSA provider by number of accounts, administering 10.6 million HSAs with $36.5 billion in assets and 7.2 million complementary CDBs (FSAs, HRAs, COBRA) as of January 31, 2026. Revenue comes from service fees, custodial fees from insurance company and bank partners holding HSA cash (~48% of revenues in fiscal 2026), and interchange fees (~15%). Custodial revenue is sensitive to interest rate levels.